The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Hamel Lawrence G since year 2005.
The trader's CIK number is 1511368.
At the time of this reporting, Hamel Lawrence G is the Chief Development Officer of Acelrx Pharmaceuticals Inc .
(stock ticker symbol ACRX).
See this page for all insider trading activities at Acelrx Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-02-28||ACRX||Acelrx Pharmaceuticals Inc||Buy||3,682||2.81||10,346|
|2018-10-15||ACRX||Acelrx Pharmaceuticals Inc||Sale||5,216||5.00||26,080|
|2018-09-24||ACRX||Acelrx Pharmaceuticals Inc||Sale||6,953||4.50||31,288|
|2017-10-02||ACRX||Acelrx Pharmaceuticals Inc||Sale||10,161||5.29||53,751|
|2017-09-25||ACRX||Acelrx Pharmaceuticals Inc||Sale||13,827||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hamel Lawrence G (Chief Development Officer of Acelrx Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.